# Long-term Study of FK949E in Elderly Bipolar Disorder Patients

> **NCT01737268** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 20 (actual)

## Conditions studied

- Bipolar Disorder
- Elderly

## Interventions

- **DRUG:** FK949E

## Key facts

- **NCT ID:** NCT01737268
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-29
- **Primary completion:** 2016-06-29
- **Final completion:** 2016-06-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737268, "Long-term Study of FK949E in Elderly Bipolar Disorder Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01737268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*